Form D · Biotechnology
BCD Bioscience, Inc.
Davis, CA · CIK 0001813229
Offering snapshot reported Mar 11, 2022 · SEC filing
- Reported sold
- $11.6M Offering amount: $13M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2022 | Initial | $11,598,050 | No comparison | 12 | SEC filing |
| Nov 12, 2020 | Amendment | $4,847,143 | $357,143vs May 27, 2020 | 15 | SEC filing |
| May 27, 2020 | Initial | $4,490,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436931
Source: Form D, filed Mar 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carlito Lebrilla | Director, Promoter |
| Steven Watkins | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
231 G Street Suite 24
Davis, CA, 95616
Davis, CA, 95616